"); //-->
|
|
||
Albendazole |
|||
|
|
|||
|
|||
|
|
|||
|   | |||
|
|
|||
|
|
Fashion Table 2 ; . This finding suggests that a significant number of immune effector T-cells was induced only late in the course of tumor growth. In order to determine whether the immunity is long-lasting, mice carrying a large PC were treated with CTX 120 mg kg ; to eliminate the tumor, and spleen cells were assayed for immune effector activity 1-3 weeks after CTX injection. Immune effector cells were detectable for at least 3 weeks after CTX injection Table 4, Experiment 1 ; . They usually persisted much longer. A higher dose of CTX 200 mg kg ; , however, eliminated the im mune effector cells Table 4, Experiment 2 ; . Spleen cells of PCbearing mice treated with CTX 120 mg kg ; were actually more effective in conferring immunity. Thus, a spleen cell PC ratio of 200 was sufficient to significantly delay PC growth Table 4, Experiment 1 ; , whereas a ratio of 1500-2000 was generally required when spleen cells of untreated mice were used see above ; . This finding suggests the presence of CTX-sensitive spleen cells suppressive of immune effector activity. Spleens of mice with a large PC, treated with CTX 120 mg kg ; , thus. Albendazole canadaCRETICOS RPN#AAC94-09-19-01: A Phase II Clinical Study of the Safety and Efficacy of Allervax Ragweed Using a Nasal Allergen Challenge Model Principal Investigator Study Period: 10 94-6 95 ; Sponsor: ImmuLogic Pharmaceutical Corporation RPN#AAC95-05-08-03: A Safety and Efficacy Study of Allervax Ragweed Using a Seasonal Model Principal Investigator Study Period: 6 95-11 95 ; Sponsor: ImmuLogic Pharmaceutical Corporation RPN#AAC96-05-24-01: An Exploratory Efficacy and Safety Study of AllervaxRagweed Peptides Using a Seasonal Model [Protocol P96-01] Revised 062796 Principal Investigator Study Period: 6 96-2 97 ; Sponsor: ImmuLogic Pharmaceutical Corporation RPN#AAC96-05-24-01: An Exploratory Efficacy and Safety Study of AllervaxRagweed Peptides Using a Seasonal Model [Protocol P96-01] Revised 062796: Safety: Early and Late Adverse Reactions to Immunotherapy Principal Investigator Study Period: 2 97-12 97 ; Sponsor: ImmuLogic Pharmaceutical Corporation RPN#AAC98-12-04-02: PNU-142731: An Exploratory Multiple Oral Dose Nasal Allergen Challenge Study in Atopic Subjects with Allergic Rhinitis Principal Investigator Study Period: 2 99-4 99 ; Sponsor: Pharmacia & Upjohn RPN#AAC99-04-05-01: A Phase I, Open-Label, Single Center Study to Explore the Safety & Tolerability of Dynavax Amb a 1 Immunostimulatory Oligonucleotide Conjugate AIC ; When Administered by a Quantitative Intradermal Procedure to Healthy Adults who are Ragweed Allergic. Principal Investigator Study Period: 5 3 99-11 ; Sponsor: Dynavax Technologies Corporation RPN#AAC98-12-29-01: Effect of Modified Rush [Cluster] Immunotherapy on Cellular and Immunologic Parameters Principal Investigator Study Period: 4 99-10 99 ; Sponsor: Dynavax Technologies Corporation RPN#AAC99-04-12-01: A Phase I, Single-Blind, Randomized, PlaceboControlled, Single-Center Study to Explore the Safety, Tolerability and Immunogenicity of Dynavax Amb a 1 Immunostimulatory Oligonucleotide Conjugate AIC ; in Healthy Adults Who are Ragweed Allergic. Principal Investigator Study Period: 6 15 00- ongoing ; Sponsor: Dynavax Technologies Corporation RPN#AAC99-09-10-04: Safety and Immunogenicity of Orally Administered Encapsulated Short Ragweed Pollen Extract Sponsor's Protocol ASR 07 ; Principal Investigator Study Period: 2 4 00-12 31 00 ; Sponsor: Allergenics, Inc. RPN#AAC00-06-30-02: A Phase I, Open-Label, Single Center Study to Explore the Safety and Tolerability of a New clinical Lot of Dynavax Amb a 1 Immunostimulatory Oligonucleotide Conjugate AIC ; When Administered by a Quantitative Intradermal Procedure to Healthy Adults Who are Ragweed Allergic. Principal Investigator Study Period: 4 21 00-8 1 ; Sponsor: Dynavax Technologies Corporation. Abstract. The pharmacokinetics of the filaricidal benzimidazole compounds UMF-078 and UMF-289 were evaluated in beagle dogs experimentally infected with Brugia pahangi. Twenty-four infected microfilaremic beagles were selected and randomly allocated into 4 treatment groups of 6 dogs each: oral PO ; UMF-078, PO UMF-289 the HCl salt form of UMF-078 ; , intramuscular IM ; UMF-078, and untreated controls. Equivalent doses of 50 mg kg of the free base were given twice a day for 3 days to the 3 groups of treated dogs. Oral absorption is rapid compared with IM dosing; the absorption half-life K01-HL ; for the IM treatment is approximately 14 hr compared with 1 and 2 hr for the PO regimen of salt and free base forms, respectively. The elimination half-lives K10-HL ; for the PO regimens are 13 and 15 hr for the salt and free base forms, respectively. Because of sustained absorption following IM dosing, the K10-HL is prolonged. In contrast to oral administration, IM dosing of UMF-078 provides sustained, relatively low plasma drug levels, with good tolerance and efficacy. Onchocerciasis caused by Onchocerca volvulus is an important public and socioeconomic health problem in tropical regions, especially in Africa. A prime need is for the treatment and control of onchocerciasis with a safe and easily administered curative drug. The ideal drug for the treatment of onchocerciasis should have the effect on O. volvulus that results either in the permanent elimination of the adult worm reservoir macrofilaricidal effect ; or in the ability of the adult female worms to produce or release microfilariae. Although suramin is the only macrofilaricidal drug for O. volvulus, it is unsuitable for routine use due to its inherent toxicity and requirement for medical supervision during the treatment. There are reports of apparent clinical cure with sustained diethylcarbamazine DEC ; treatment in lightly infected onchocerciasis patients and evidence of degenerate worms in nodules after treatment.1, 2 However, it is generally accepted that DEC is microfilaricidal and is not a macrofilaricide for O. volvulus.3, 4 This drug can cause severe adverse effects in onchocerciasis patients Mazzotti reaction ; , which also limits its use. Ivermectin has a potent microfilaricidal activity and a lower incidence of adverse effects than DEC and is now considered the drug of choice for onchocerciasis.5 However, the treatment has to be repeated because the drug has no macrofilaricidal effect. At present, no drug has been shown to eliminate the adult worms permanently without causing severe toxicity.6 Benzimidazoles, as a chemical class, have frequently shown good macrofilaricidal activity against filariae. Mebendazole and flubendazole are thought to disrupt embryogenesis in O. volvulus, and they do not produce the severe Mazzotti reaction.7, 8 However, poor oral absorption of mebendazole and a prolonged dosing regimen makes its routine use impractical. In addition, abscesses at the site of injection of flubendazole limits its use.8 For lymphatic filariasis, single dose treatment of either ivermectin or DEC in combination with albendazole can produce a 99% clearance of microfilaremia up to 1 year after treatment.9, 10 This finding has led to the recommendation of using these combinations for large-scale lymphatic filariasis elimination programs.11 UMF-078 [methyl ; -[5- 4-fluorophenyl ; aminomethyl1Hbenzimidazole-2-yl] carbamate], under investigation by the World Health Organization, is a benzimidazole carbamate compound that is virtually insoluble in basic and neutral buffers the solubility in water is 8 g ml ; .12 The drug appears to be metabolized into at least 5 putative metabolites: 1 ; decarbamoylated UMF-078, 2 ; UMF-060 [methyl ; -[5- 4-fluorophenyl ; 3 ; decarbamoylated UMF-060, 4 ; flubendazole [methyl ; -[5 4-fluorobenzoyl ; -1H-benzimidazole2-yl]carbamate], and 5 ; decarbamoylated flubendazole.13 Only UMF-060 and flubendazole were analyzed in this study because they are the principal metabolites found in plasma and may contribute to efficacy. Flubendazole has been shown to have macrofilaricidal activity by killing female worms when subcutaneously or orally administered to animals infected with B. pahangi.14, 15 Additionally, flubendazole administered subcutaneously 9 weeks before infection with B. pahangi showed chemoprophylactic activity in the jird model.16 Previous studies proved that UMF-078 was highly active against lymphatic filariasis in beagle dogs experimentally infected with B. pahangi, using dosages ranging from 12.5 mg kg to 50 mg kg administered intramuscularly for 3 consecutive daily doses. UMF-078 was also highly active when given orally on 3 occasions at daily doses of 25, 50, and 100 mg kg. It was noted that 100% efficacy was achieved with an intramuscular IM ; dosage of 50 mg kg for 3 consecutive days and administration of 50 mg kg twice a day for 3 days was at least 89% effective McCall JW, Dzimianski MT, unpublished data ; . The objective of this study was to determine the bioavailability and pharmacokinetics of oral PO ; and IM UMF-078 in infected dogs at a dosage expected to be curative. A second objective was to compare the bioavailability and pharmacokinetics of the oral free base, UMF-078, with its dihydrochloride salt, UMF-289 a water-soluble salt form of UMF-078 and strattera. However raise the question as to whether the HDL upregulation mediated by the PPAR agonists is an effect solely mediated through PPAR activation. Many of the genes which were found to be regulated table 2 ; are involved in lipid metabolism, and have previously been shown to be regulated by PPAR-agonists. This includes Bifunctional enzyme peroxisomal -oxidation ; 28 ; , Cyp4A10 microsomal -hydroxylation ; 29 ; , acetyl-CoA C-acetyltransferase mitochondrial -oxidation ; 30 ; , beta-ketothiolase mitochondrial -oxidation ; , long-chain-acyl-CoA dehydrogenase mitochondrial -oxidation ; 31 ; , long-chain-fatty-acyl-CoA synthetase fatty acid activation ; 32 ; , ACBP fatty acid compartmentalization ; 33 ; , Apo-CIII lipoprotein metabolism ; 11 ; , HMG-CoA-Synthase ketone body synthesis ; 34 ; , and malic enzyme NADPH supply for fatty acid synthesis ; 35 ; . It has also previously been shown that the liver GLUT-2 promotor contains a functional PPRE 36 ; . In experiments where animals were dosed for 10 days with Wy-14643 and NNC61-4706 Table 2 ; , gene regulations were found to be very similar to those observed in animals dosed for 4 days. Data indicate a slight tendency toward larger gene expression changes after 4 days of dosing for a number of genes which might reflect minor transcriptional feed back regulation during longer treatment protocols. In addition to the compound mediated transcriptional effects, the high cholesterol diet used may also have influenced the expression profiles for a number of the genes shown in Table 2. Recently a microarray study of the transcriptional responses to a high cholesterol diet reported 69 genes as regulated in livers of mice 37 ; . Genes significantly downregulated by the cholesterol component of the diet included malic enzyme, ACBP, and HMG-CoA-Synthase. These were also regulated in the present study Table 2 ; and are as described above known PPAR target genes. Thus, regulations of these genes were most likely both affected by the ligand mediated lowering of total cholesterol Fig.3 ; and by the direct PPAR mediated transcriptional activation. This emphasizes the importance of choice of diet for gene expression studies and suggests that predictive gene sets may be most accurate when used in animal-models similar to the one in which they were identified. When searching for possible correlations between the observed in vitro PPAR efficacies for each compound and the expression-profiles of the regulated genes a number of very clear relationships were identified Fig. 4a ; . The best linear regressions, based on data from both Northern blotting and microarrays, were found.
Handheld hiv cme center q& a forum publications resources site info faq abx guide poc-it center infection control ccghe viral hepatitis center center for global health jh division of infectious diseases abx guide q& a editor in chief joel gallant, md, mph managing editor adriana andrade, md, mph pharmacology editor paul pham, pharmd, bcps q& a patient drug interactions tuberculous lymphadentis posted on aug 25, 2005 my mom is suffering from tuberculous lymphadentis on the right supraclavicular lymphnode and lariam. Here is a list of current warrants issued by the Aztec Municipal Court. If your name appears on this list, please contact the Court at: 505-334-7640 to clear up your warrant. Aztec Municipal Court is open 7: 00 to M-F. Ciprofloxacin induced bradycardia was reported as a single case report from Srinagar61. The appearance of new cysticercosis nodules with albendazole therapy has been documented in a 16 year old girl 62 . The familial tendency in hypersensitivity reactions to co-trimoxazole has been documented63 and pletal. In Mumbai. "The timing is right, " says Hisamaro Garugu, a 30-year veteran in research and marketing at Eisai and architect of this venture. The introduction of composition of matter patents in January 2005 has improved intellectual property protection, and India's top-notch sourcing industry in such areas as IT and pharmaceuticals as well as its large pool of scientific talent offer additional incentives. Heading up the new company is Managing Director Deepak Naik, a pharmaceutical industry veteran. Naik will establish a network of "Health Care Executives" to be deployed in key cities throughout India to support up to 4, 000 doctors, with a focus on human health care hhc ; . Eisai aims to serve the market with its portfolio of blockbuster products, including Aciphex Pariet and Aricept. Albendazole dosageAppendix Table 8. The efficacy of albendazole at doses other than 400 mg single dose in E. vermicularis infections. Published studies through March 1998. This action was in response to lawsuits filed by planned parenthood federation of america, the american civil liberties union, the national abortion federation and the center for reproductive rights and zerit and Cheap albendazole online. Recently negotiated a second sale of 300, 000 copies of the New Mother's Guide to Breastfeeding based on the recently developed "Guidelines for Special Sales" document 2003 ; , which provides procedural guidance on marketing of books and other AAP publications. It has had only limited distribution. It states that the editor or author of a publication shall be contacted prior to finalization of a sale and that there must be a statement that the book is "A gift from " and that the book is a product of the AAP was not influenced by the purchaser distributor of the book. Also, placement of this acknowledgement must not imply any endorsement of the purchaser's product. These are steps in the right direction. Dr. Meek and the SOBr Leadership Team were notified of this second sale. Of significance, the Ross acknowledgment will only be on the inside of the front cover. While Chapter 5 of the AAP Board of Directors Policy and Procedure Manual gave some reasonable guidance to the process, this manual is not available to AAP members or to staff. It can be accessed on the AAP Web site only by. ` 8. Castillo JA, Palomo-Canales J, Garcia JJ et al. Preparation and characterization of albendazole b-cyclodextrin complexes. Drug Dev Ind Pharm 1999; 25: 12418. ` ` 9. Garcia JJ, Bolas-Fernandez F, Torrado JJ. Quantitative determination of albendazole and its main metabolites in plasma. J Chromatogr B Biomed Sci Appl 1999; 723: 26571. Sarin R, Dash AP, Dua VK. Alebndazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography. J Chromat B Analyt Technol Biomed Life Sci 2004; 799: 2338. Gould S, Scott RC. 2-Hydroxypropyl-b-cyclodextrin HP-b-CD ; : a toxicology review. Food Chem Toxicol 2005; 43: 14519. Solana HD, Sallovitz JM, Najle R et al. Liver sulphoxidative metabolism of albendazole in rat: enantioselectivity and effect of methimazole. Methods Find Exp Clin Pharmacol 2000; 22: 838. Capece BP, Castells G, Perez F et al. Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep. Vet Res Commun 2000; 24: 33948. Solana HD, Sallovitz JM, Lanusse CE et al. Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites. Methods Find Exp Clin Pharmacol 2002; 24: 713. Bolas-Fernandez F, Rama-Iniguez S, Torrado JJ. Ex vivo anthelmintic activity of albendazole-sulphoxide enantiomers. J Parasitol 2004; 90: 4079 and copegus. The mitotic spindles, disruption of which would consequently lead to cell death [25]. However, beside the tubulin, other mechanisms of action have been described for the BZs including disruption of the energy metabolism of the host. In fact initial studies of the mode of action of BZs focused on their role in carbohydrate metabolism as these compounds have been shown to inhibit glucose uptake both in vitro and in vivo in many helminth species. Albebdazole has been shown to block glucose uptake by larval and adult stages of susceptible parasites, depleting their glycogen stores and decreasing formation of ATP leading to the death of the parasite [23]. Differences in energy metabolism between normal and malignant cells has also been described, and it is well known that in many malignant cell lines, glucose utilization is several fold higher than in normal cells [26]. In the rat HCC cell line HTC, the rate of glucose uptake is 40-fold greater than that of the normal liver cells [27]. Moreover, it has been shown that 2-Deoxyglucose 2-DG ; , a glucose analogue that competitively inhibits cellular uptake and utilization of glucose causes death of malignant cells. Data from our work in nude mice suggests that, at the higher dose of the 300 mg kg per day, albendazole presumably reaches the necessary concentrations required to suppress tumor formation. The very high rate of metabolism of albendazole in mice and the poor blood supply to the subcutaneous tumor, are amongst a number of factors that could account for the high dose of the drug required to suppress tumor growth in these animals. The MPI data also conrm the ability of albendazole to reduce tumor proliferation rate. The Ki-67 antigen used in this assay is tightly linked to proliferation and has been used in a large number of studies to estimate the growth fraction of tumors [15]. In conclusion, the present report reveals for the rst time that, albendazole a benzimidazole carbamate with extensive clinical use as an anthelmintic drug, can also inhibit HCC cell proliferation under both in vitro and in vivo experimental conditions. These results led us to examine the drug in patients with liver cancer refractory to all other available treatments. Preliminary results obtained here, have basically conrmed our experimental data, in suggesting the possibility of potential usefulness of albendazole in the treatment of liver cancers unpublished data. Date: Wed, 21 Nov 2001 08: 48: -0800 From: Bob Strickland bob rickland lmco Subject: Highway 17 Fare Increase To: hwyl7 scmtd Cc: Bob Strickland rls cruzio X-Mailer: Mozilla 4.61 [en] WinNT; U ; X-Accept-Language: en Hello, The proposed 40% fare increase for CALTRAIN passengers might be more palatable if it were accompanied by service improvements. 1 ; Improve Rush Hour Service Frequency: During rush hour about 5: 30-7: OOPM ; hiway- 17 service frequency is reduced from 15 minutes to about 30 minutes. It would be very helpful if there were more hiway- 17 service between 5: 30PM and 7: OOPM. That's when most of the south bound trains arrive * at the Diridon Station. During this time 3 of the 10 trains * #68, #72, #82 ; have good i.e. less than 10 minutes ; connections. However, if the train is late, the next bus is 30-40 minutes later! 2 ; Monthly Hiway-17KALTRAIN pass sticker: It's a nuisance keeping enough quarters and dollar bills to feed the fare box on a daily basis. Since we already pay between -5 per month for a train bus transit pass, it's hard to justify buying a monthly metro&a pass. It would be really convenient if we could buy a monthly hiway- sticker for the CALTRAIN pass. It doesn't seem fair to increase the CALTRAIN surcharge 40% when you're trying for a 25% increase. Even a 25% increase seems large in the current economy. If you must levy most of the fare increase on CALTRAIN customers, please consider providing improvements in return. Thank you, Bob Strickland 123 McGivem Way Santa Cruz, CA 95060 831 ; 427-3136. Albendazole for menIn recent years, rates of cesarean sections in Utah have increased Figure 1 ; , as was the case for National rates, highlighted in the review of literature. These rates hovered around 16 per 100 deliveries from 1997 to 1999, after which a sharp and steady increase occurred from 16.6 per 100 deliveries in the year 2000, to 20.7 in 2004, an increase of over 4 per 100 deliveries during a short period of 4 years. The rate of birth trauma was 6 per 1, 000 live births, which amounts to 958 births with trauma during the time period 2001-2004. Nearly 82% of all births were vaginal. Table 1 shows the frequency and percentage distribution of discharges by their various characteristics. The overall rate of cesarean deliveries was 18.1% for singleton births ; . Over 19% 5, 894 ; of all c-sections involved complications while 81% or 25, 238 cesarean deliveries had no complications. As in the case of overall cesarean deliveries Figure 1 ; , there is a substantial increase in cesarean and buy strattera. For children with ADHD following the introduction of ATX. Pharmacotherapy. 2005; 25 11 ; : 1541-49. ; Van Brunt served as principal author of the study. Study concept and design were contributed by Van Brunt, Johnston, and Pohl, with input from Ye and Ohara. Data collection was the work of Ye and Van Brunt, with input from Johnston and Pohl; data interpretation was primarily the work of Ye, Van Brunt, and Johnston, with input from Pohl and Ohara. Drafting of the manuscript and its revision were primarily the work of Van Brunt, with input from Johnston and the other coauthors. The ionization mechanism dominates if the sulfonylation is carried out in a polar solvent. Zero order kinetics is observed with reactive aromatics e.g. mesitylene ; . Third order kinetics is observed with less reactive aromatics e.g. benzene ; , since the rate determining step is the attack of aromatic compound upon the sulfonyl chloride-Lewis acid complex. 40 ; A solvent affects the solvation of sulfonyl chloride-Lewis acid complexes and thus solvents that solvate the complex efficiently should be quite good solvents for Lewis acid catalyzed sulfonylation. Traditional Lewis acid catalysts form stable complexes with sulfonyl chlorides and sulfone products. The complexes between the Lewis acid and sulfone could decrease catalyst activity. Kinetics for aluminum trichloride catalyzed sulfonylation has been studied. Benzenesulfonyl chloride was used as a solvent and reagent. The. Albendazole dosingAlbendazole tabletAlbendazle, lbendazole, albendazile, albenxazole, albendazoel, wlbendazole, albenrazole, albendwzole, albbendazole, albendazol, albendaaole, albrndazole, albendszole, albendazolw, aalbendazole, albedazole, albencazole, albendzaole, qlbendazole, albendaz0le, albenazole, albendazolr, labendazole, albendazol4, algendazole, ablendazole, albendxzole, albenddazole, albemdazole, allbendazole, albendazlle, albnedazole, albendazols, albendaole, albendasole, albendaozle, albeendazole, albejdazole, albendazold, albenfazole, albendazloe, albendazoole. |
||
|
|
© 2007 | ||